The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: Hi guys, congrats on the quarter.
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: So, now that we have this acquisition in the mix, how should we model sales for the next few quarters? Like, what's the growth potential?
LSEG STREETEVENTS | www.lseg.com | Contact Us
consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies.
NOVEMBER 19, 2025 / 10:00PM, VVOS.OQ - Q3 2025 Vivos Therapeutics Inc Earnings Call
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: Okay, so, okay, so there's an upfront investment in personnel and then sort of a delayed, benefit in terms of revenues. Like how big is that
GAAP? Is it a quarter or two?
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: Okay. And then in terms of the additional operating expenses that we saw in this quarter, presumably some of that was sort of one-time or
acquisition related. I'm just wondering like what would be reasonable in terms of operating expenses like next quarter or the quarter after.
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: Okay. Thanks Kirk. Last question, on cash flow breakeven, can you give us an update on, your kind of your goal there?
LSEG STREETEVENTS | www.lseg.com | Contact Us
consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies.
NOVEMBER 19, 2025 / 10:00PM, VVOS.OQ - Q3 2025 Vivos Therapeutics Inc Earnings Call
Question: Lucas Ward - Ascendiant Capital Markets LLC - Analyst
: Okay, thank you very much.
Question: Robert Sassoon - Water Tower Research LLC - Analyst
: With the exceptional quarter, question under the new business model and with revenues on the rise, how should investors look at the
company now and in six months from now?
Question: Robert Sassoon - Water Tower Research LLC - Analyst
: That sounds like a very interesting development we'll definitely monitor that maybe a question to Brad, how does the recognition of revenue
differ between the various models?
Question: Robert Sassoon - Water Tower Research LLC - Analyst
: Okay, thank you for that and I'll jump back in the queue.
| 
